Clinical trial Recruiting at 3 sites Interventional Ages 0 Hours and up

Optimising breathing support at extubation for very preterm infants

Official title: PrePAP: Pre-Extubation Continuous Positive Airway Pressure in Very Preterm Infants: A Randomised Controlled Trial

Run by Murdoch Childrens Research Institute · NCT07251790 · Data updated 2026-11-12

This trial will try starting nasal CPAP before removing the breathing tube versus starting it after extubation to see if that reduces oxygen drops in very preterm infants.

Quick facts

Study typeInterventional
Ages0 Hours and up
SexAll
Enrollment134 (estimated)
SponsorMurdoch Childrens Research Institute
Academic / other
Locations3 sites (Melbourne, Victoria and 2 other locations)
StatusRecruiting
StartedMay 4, 2026
Main results expectedMarch 31, 2028
Study endsMarch 31, 2028
Registry record updatedAugust 26, 2026
Trial IDNCT07251790 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants born at 22+0 to 29+6 weeks gestation, admitted to a participating NICU, who have been on invasive ventilation for at least 4 hours and are being electively extubated to nCPAP for the first time with parental consent are ideal candidates.

Probably not a fit

Infants with major congenital cardiac/respiratory/gastrointestinal anomalies, severe pulmonary hypoplasia, those outside the gestational age window, or those requiring emergency extubation are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two common extubation approaches in very preterm infants born between 22+0 and 29+6 weeks who are being electively extubated to nCPAP. One group receives nCPAP started prior to removal of the endotracheal tube (prePAP) and the other group receives the usual practice of nCPAP started after extubation. The primary outcome is oxygen desaturation in the four hours immediately after extubation, with additional monitoring for extubation failure, re‑intubation and short-term respiratory outcomes. The trial is conducted in participating NICUs in Melbourne, Australia.

Why it matters

Potential benefit: If successful, starting nCPAP before extubation could reduce early oxygen desaturations and lower the risk of re‑intubation and lung injury in very preterm infants.

How similar studies have gone: Small observational reports and physiologic rationale suggest prePAP may improve stability at extubation, but robust randomized evidence is currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The infant is admitted to participating NICU
* The infant is born between 22+0 to 29+6 weeks gestational age
* The infant has been on a form of invasive mechanical ventilation for at least 4 hours
* The infant is being electively extubated for the first time from invasive mechanical ventilation to nCPAP
* The infant is clinically stable (as per clinical and research team consensus)
* The parent(s) or legal guardian(s) provides prospective informed consent.

Exclusion Criteria:

* The infant is born \<22 weeks or \>30 weeks gestational age
* The infant has a major congenital anomaly involving the cardiac, respiratory or gastrointestinal systems, or a known genetic syndrome or diagnosis that might affect respiratory course and outcomes
* The infant has severe pulmonary hypoplasia due to anhydramnios or oligohydramnios before 22 weeks in which the neonatal clinician anticipates that pulmonary hypoplasia related respiratory failure will be the major respiratory problem in early postnatal life
* The infant is receiving invasive mechanical ventilation via nasotracheal intubation
* The infant is planned for extubation to any other mode of non-invasive respiratory support than nCPAP, or no respiratory support
* Refusal of informed consent from the parent(s), or the infant does not have a guardian who can provide informed consent.

Where it's running

  • The Royal Women's Hospital
    Melbourne, Victoria, Australia
    Recruiting
  • The Royal Children's Hospital
    Parkville, Victoria, Australia
    Recruiting
  • Joan Kirner Women's and Children's Hospital
    Saint Albans, Victoria, Australia
    Recruiting

Study contacts

  • Principal investigator: Georgia S Stephen, BBmedSc BBiomedSc(Hons) — Murdoch Childrens Research Institute
  • Study coordinator: Georgia S Stephen, BBmedSc BBiomedSc(Hons)
  • Email: georgia.stephen@mcri.edu.au
  • Phone: 61(0)424701924

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.